Xeomin 100 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26F7NPN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,007
Award facts
- Contract value 100% obligated
- $12,006.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $12,006.80, was awarded on January 13, 2026, to AmerisourceBergen Drug Corp (a subsidiary of Cencora, Inc.) for the supply of Xeomin 100 Unit Vials. The award is not set-aside and was competitively awarded through the Defense Logistics Agency (DLA), the federal agency responsible for supplying medical and pharmaceutical products to the Department of Defense and military healthcare systems. Performance will be completed by February 4, 2026, at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through its comprehensive portfolio of pharmaceutical products and medical supplies.
This delivery order is executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. This prime IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a vast range of pharmaceutical products and medical supplies to military healthcare programs worldwide. The DLA Troop Support is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple awards for separate regions, demonstrating the strategic importance of contractors like AmerisourceBergen in the federal medical supply chain. The firm fixed-price structure and competitive nature of this award reflect the contractor's demonstrated capability to meet federal procurement requirements for essential pharmaceutical commodities.
Quick answers
Who was awarded contract SPE2DR26F7NPN?
SPE2DR26F7NPN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F7NPN worth?
The government has obligated $12,007 on SPE2DR26F7NPN.
Is contract SPE2DR26F7NPN an order under another contract?
Yes. SPE2DR26F7NPN is a delivery order under SPE2DR25D7059, an indefinite delivery contract.
Was contract SPE2DR26F7NPN competed?
The extent of competition for SPE2DR26F7NPN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award